Viewing Study NCT03024450


Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2026-02-20 @ 6:40 PM
Study NCT ID: NCT03024450
Status: COMPLETED
Last Update Posted: 2017-01-24
First Post: 2017-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Based Therapy in HER2 Positive AGC
Sponsor: Shanghai Zhongshan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastric cancer View
None HER2 View
None trastuzumab View
None prognosis View